Kirkland & Ellis Reps Bristol Myers In $175M IPierian Buy
Bristol-Myers Squibb Co. has acquired iPierian Inc., a California biotechnology company that develops treatments for neurodegenerative diseases, for $175 million in cash upfront and potentially up to another $550 million in...To view the full article, register now.
Already a subscriber? Click here to view full article